Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Blackhawk Growth Corp C.BLR

Alternate Symbol(s):  C.BLR.WT | BLRZF

Blackhawk Growth Corp. is a Canada-based investment holding company. The Company invests in equity and debt instruments of companies to generate positive returns for shareholders. It focuses on investing in multiple companies across a variety of sectors across North America. The Company has focused its investments on the health, cannabis and cannabidiol (CBD) industries, in both Canada and the United States.


CSE:BLR - Post by User

Bullboard Posts
Post by ecosleuthon Mar 10, 2008 3:11pm
419 Views
Post# 14634250

Orebodies News Release

Orebodies News ReleaseTORONTO, March 10, 2008 -- Canadian Orebodies Inc. ("Orebodies") is pleased to announce that it has acquired Baltic's interest in the Coral Rapids Project, the Hawkins Project, and the Webequie Area Projects as a result of the completion of the arrangement (the "Arrangement") of Baltic Resources Inc. ("Baltic") involving Orebodies, PhosCan Chemical Corp. ("PhosCan") and 1366825 Alberta Ltd.

The Arrangement was approved by the shareholders of Baltic on March 4, 2008, and by the Court of Queen's Bench of Alberta on March 7, 2008 and became effective today. For more information concerning the Arrangement, please refer to Baltic's management information circular dated February 1, 2008, filed on SEDAR at www.sedar.com.

Pursuant to the Arrangement, Baltic transferred to Orebodies all of Baltic's assets other than Baltic's interest in the Martison Phosphate Project and 90% of the proceeds of warrants and options of Baltic exercised since October 29, 2007, and Orebodies has assumed all of Baltic's liabilities, other than advances made by PhosCan on Baltic's behalf in respect of the Martison Phosphate Project.

Under the Arrangement, Baltic shareholders as of market close March 7, 2008, received in exchange for each common share of Baltic, one common share of Orebodies, and Baltic options have been exchanged for Orebodies options which entitle the holders thereof to acquire 800,000 Orebodies shares at an exercise price of $0.03 per share until August 15, 2010. Orebodies is also committed to issuing up to 420,000 Orebodies shares upon the exercise of the outstanding Baltic warrants in exchange for $0.04 per Orebodies common share until March 29, 2009.

The listing of the shares of Orebodies has been conditionally accepted by the TSX Venture Exchange, subject to the filing of certain post-closing documentation. Orebodies will have 37,030,899 shares outstanding and 38,090,899 fully diluted.

Gordon McKinnon, Chief Executive Officer of Orebodies, said "We are pleased to finalize the arrangement to consolidate 100% interest in the Martison project with PhosCan. In addition, I am eager to move forward with Canadian Orebodies and we will waste no time doing so. Orebodies is acquiring quality projects through this transaction, all with the potential to create excellent value for our shareholders. This is an exciting time for us and we look forward to a strong year with the new company."
Bullboard Posts